{"transactions":[{"id":4697,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-04","kind":"exercise","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options before their expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.44,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":4696,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Exercise of stock options before their expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested and exercisable."}],"balance_after":250000,"derivative":{"exercise_price":2.44,"expiration_date":"2026-09-12","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":4695,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":119212,"price":24.7552,"value":2951116.9024,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested stock options scheduled to expire on September 12, 2026. The shares were sold solely to cover the aggregate exercise price and applicable tax withholding obligations. The Reporting Person retained all remaining shares acquired upon exercise."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.5550 to $25.1200, inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1182871,"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":4694,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-04","kind":"exercise","planned":false,"acquired":true,"shares":250000,"price":2.44,"value":610000.0,"ownership":{"direct":true},"balance_after":1302083,"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":4693,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":84900,"price":25.3201,"value":2149676.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested stock options scheduled to expire on September 12, 2026. The shares were sold solely to cover the aggregate exercise price and applicable tax withholding obligations. The Reporting Person retained all remaining shares acquired upon exercise."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.3200 to $25.3300, inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1052083,"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":4692,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-03","kind":"sale","planned":false,"acquired":false,"shares":393100,"price":24.7604,"value":9733313.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested stock options scheduled to expire on September 12, 2026. The shares were sold solely to cover the aggregate exercise price and applicable tax withholding obligations. The Reporting Person retained all remaining shares acquired upon exercise."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.3200 to $25.3100, inclusive. The reporting person undertakes to provide to Caris Life Sciences, Inc., any security holder of Caris Life Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1136983,"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":4691,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-09-04T20:59:59.000Z","date":"2026-09-03","kind":"exercise","planned":false,"acquired":true,"shares":1000000,"price":2.44,"value":2440000.0,"ownership":{"direct":true},"balance_after":1530083,"source":{"system":"sec-edgar","filing":"0002071953-26-000007","document":"wk-form4_1788555596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2071953/000207195326000007/wk-form4_1788555596.xml","form_type":"4"}},{"id":775466,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-05-18T20:23:15.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":13856,"price":15.25,"value":211304.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld for the payment of taxes on the vesting and settlement of RSUs."}],"balance_after":530083,"source":{"system":"sec-edgar","filing":"0002071953-26-000004","document":"wk-form4_1779135792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000207195326000004/wk-form4_1779135792.xml","form_type":"4"}},{"id":851560,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2026-03-10T21:59:58.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":83162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units which vest in accordance with the applicable grant agreement."}],"balance_after":543939,"source":{"system":"sec-edgar","filing":"0002071953-26-000002","document":"wk-form4_1773179995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000207195326000002/wk-form4_1773179995.xml","form_type":"4"}},{"id":1003939,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-11-10T13:11:33.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":400,"price":23.85,"value":9540.0,"ownership":{"direct":true},"balance_after":460777,"source":{"system":"sec-edgar","filing":"0002071953-25-000008","document":"wk-form4_1762780290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000207195325000008/wk-form4_1762780290.xml","form_type":"4"}},{"id":1067999,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-08-14T00:07:06.000Z","date":"2025-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":63509,"price":29.75,"value":1889392.75,"ownership":{"direct":true},"balance_after":460377,"source":{"system":"sec-edgar","filing":"0001104659-25-077775","document":"tm2523446-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925077775/tm2523446-2_4seq1.xml","form_type":"4"}},{"id":1104159,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2025-06-23T22:41:24.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.44,"expiration_date":"2025-06-23","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-25-061815","document":"tm2518641-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061815/tm2518641-9_4seq1.xml","form_type":"4"}},{"id":1104158,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option","published_at":"2025-06-23T22:41:24.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested 60% at grant and will vest 20% on August 11, 2025 and 20% on August 11, 2026. These securities were previously reported on the Reporting Person's Form 3."}],"balance_after":750000,"derivative":{"exercise_price":18.6,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001104659-25-061815","document":"tm2518641-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061815/tm2518641-9_4seq1.xml","form_type":"4"}},{"id":1104157,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-06-23T22:41:24.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":34782,"price":27.25,"value":947809.5,"ownership":{"direct":true},"balance_after":523886,"source":{"system":"sec-edgar","filing":"0001104659-25-061815","document":"tm2518641-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061815/tm2518641-9_4seq1.xml","form_type":"4"}},{"id":1104156,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-06-23T22:41:24.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":75000,"price":2.44,"value":183000.0,"ownership":{"direct":true},"balance_after":558668,"source":{"system":"sec-edgar","filing":"0001104659-25-061815","document":"tm2518641-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061815/tm2518641-9_4seq1.xml","form_type":"4"}},{"id":1104155,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-06-23T22:41:24.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":132428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an award of restricted stock units which vest in accordance with the applicable grant agreement."}],"balance_after":483668,"source":{"system":"sec-edgar","filing":"0001104659-25-061815","document":"tm2518641-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061815/tm2518641-9_4seq1.xml","form_type":"4"}},{"id":1104154,"issuer":{"id":3706,"kind":"organization","name":"Caris Life Sciences, Inc.","symbol":"CAI"},"owners":[{"id":10173,"kind":"person","name":"Spetzler David Baxley","position":1,"cik":"0002071953","reported_name":"Spetzler David Baxley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2025-06-23T22:41:24.000Z","date":"2025-03-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":700509,"price":18.6,"value":13029467.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock surrendered to the Issuer as repayment for an outstanding promissory note."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 151,750 shares of Common Stock underlying restricted stock units which vest in accordance with the applicable grant agreements, which securities were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025."}],"balance_after":351240,"source":{"system":"sec-edgar","filing":"0001104659-25-061815","document":"tm2518641-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2019410/000110465925061815/tm2518641-9_4seq1.xml","form_type":"4"}}]}